Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Tegoprazan- Versus PPI-based H. Pylori Eradication

View source ↗

Summary

A clinical trial at Soonchunhyang University Hospital is evaluating tegoprazan versus a proton pump inhibitor-based regimen for Helicobacter pylori infection an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proton pump inhibitors (PPI) regimen
  • Tegoprazan (tegoprazan)

Snippet

Sponsor: Soonchunhyang University Hospital | Conditions: H.Pylori Infection | Status: RECRUITING